全文获取类型
收费全文 | 333183篇 |
免费 | 7554篇 |
国内免费 | 347篇 |
专业分类
耳鼻咽喉 | 3285篇 |
儿科学 | 11254篇 |
妇产科学 | 6691篇 |
基础医学 | 39295篇 |
口腔科学 | 6835篇 |
临床医学 | 21230篇 |
内科学 | 65953篇 |
皮肤病学 | 5092篇 |
神经病学 | 29119篇 |
特种医学 | 12748篇 |
外国民族医学 | 1篇 |
外科学 | 46978篇 |
综合类 | 3019篇 |
一般理论 | 24篇 |
预防医学 | 37162篇 |
眼科学 | 6983篇 |
药学 | 21882篇 |
中国医学 | 1281篇 |
肿瘤学 | 22252篇 |
出版年
2023年 | 816篇 |
2021年 | 2432篇 |
2020年 | 1366篇 |
2019年 | 2813篇 |
2018年 | 26323篇 |
2017年 | 19921篇 |
2016年 | 22106篇 |
2015年 | 4259篇 |
2014年 | 4454篇 |
2013年 | 6421篇 |
2012年 | 16690篇 |
2011年 | 30955篇 |
2010年 | 23549篇 |
2009年 | 15014篇 |
2008年 | 27646篇 |
2007年 | 30434篇 |
2006年 | 9384篇 |
2005年 | 10609篇 |
2004年 | 11190篇 |
2003年 | 11658篇 |
2002年 | 9435篇 |
2001年 | 5120篇 |
2000年 | 5838篇 |
1999年 | 4285篇 |
1998年 | 888篇 |
1997年 | 637篇 |
1992年 | 2246篇 |
1991年 | 2068篇 |
1990年 | 2092篇 |
1989年 | 1751篇 |
1988年 | 1653篇 |
1987年 | 1539篇 |
1986年 | 1562篇 |
1985年 | 1477篇 |
1984年 | 1053篇 |
1983年 | 911篇 |
1979年 | 1207篇 |
1978年 | 812篇 |
1977年 | 782篇 |
1976年 | 749篇 |
1975年 | 880篇 |
1974年 | 1138篇 |
1973年 | 1166篇 |
1972年 | 1111篇 |
1971年 | 1076篇 |
1970年 | 1025篇 |
1969年 | 1102篇 |
1968年 | 1122篇 |
1967年 | 978篇 |
1966年 | 883篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep
下载免费PDF全文
![点击此处可从《Journal of pineal research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Flavio Torres Alejandro González‐Candia Camilo Montt Germán Ebensperger Magdalena Chubretovic María Serón‐Ferré Roberto V. Reyes Aníbal J. Llanos Emilio A. Herrera 《Journal of pineal research》2015,58(3):362-373
Pulmonary hypertension of the newborn (PHN) constitutes a critical condition with severe cardiovascular and neurological consequences. One of its main causes is hypoxia during gestation, and thus, it is a public health concern in populations living above 2500 m. Although some mechanisms are recognized, the pathophysiological facts that lead to PHN are not fully understood, which explains the lack of an effective treatment. Oxidative stress is one of the proposed mechanisms inducing pulmonary vascular dysfunction and PHN. Therefore, we assessed whether melatonin, a potent antioxidant, improves pulmonary vascular function. Twelve newborn sheep were gestated, born, and raised at 3600 meters. At 3 days old, lambs were catheterized and daily cardiovascular measurements were recorded. Lambs were divided into two groups, one received daily vehicle as control and another received daily melatonin (1 mg/kg/d), for 8 days. At 11 days old, lung tissue and small pulmonary arteries (SPA) were collected. Melatonin decreased pulmonary pressure and resistance for the first 3 days of treatment. Further, melatonin significantly improved the vasodilator function of SPA, enhancing the endothelial‐ and muscular‐dependent pathways. This was associated with an enhanced nitric oxide‐dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue. Further, melatonin reduced the pulmonary oxidative stress markers and increased enzymatic and nonenzymatic antioxidant capacity. Finally, these effects were associated with an increase of lumen diameter and a mild decrease in the wall of the pulmonary arteries. These outcomes support the use of melatonin as an adjuvant in the treatment for PHN. 相似文献
35.
36.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
37.
38.
39.
M. Alexandra Friedman Charlotte M. Niznik Janelle R. Bolden Lynn M. Yee 《Journal of community health》2016,41(2):354-358
While peer support has been investigated in multiple clinical contexts, its application to the postpartum setting is unknown. The aim was to assess acceptability of a postpartum peer support program for women with diabetes. Observational survey-based needs assessment of forty low-income women with diabetes, receiving care at a major medical institution. Mean age and gravidity were 30.7 years and 3.15 ± 1.67 respectively. 45 % expressed interest in a “buddy.” There was no significant difference between groups desiring and not desiring this program. A majority of respondents desired telephone, text messaging, and in-person contacts (79.2, 72.1, 83.8 %), with 72.5 % of patients desiring diabetes-related activities during clinic waiting time. Many women desire a postpartum diabetes reciprocal peer program for support outside of clinician visits. Patients are receptive to educational services during their wait and outside of clinic time, a potentially valuable opportunity to share important health information. 相似文献
40.
José Antonio Pereira Miguel Pera Manuel López-Cano Marta Pascual Sandra Alonso Silvia Salvans Marta Jiménez-Toscano Alba González-Martín Luis Grande-Posa 《Cirugía espa?ola》2019,97(1):20-26